Dr. Ezekiel Emanuel and Senior Analyst at the Center for Public Integrity Wendell Potter discuss the controversy concerning the price of Daraprim, a potentially lifesaving drug, which
was increased from $13.50 to $750 after the company that produces the drug was bought out.Sept. 21, 2015
UP NEXT
President Biden signs debt ceiling bill into law
02:57
NASA administrator: The future of space is collaborative
05:20
Alex Newell discusses the cathartic performances in 'Shucked'
05:55
'We have a major crisis': Mayor calls for federal funding for mental health
07:30
'Why not you?': Bestselling author offers her advice to dreamers
07:33
'A blowout number': U.S. employers added 339,000 jobs in May